{
    "id": 17317,
    "fullName": "ARID1A Q456*",
    "impact": "nonsense",
    "proteinEffect": "loss of function",
    "geneVariantDescriptions": [
        {
            "description": "ARID1A Q456* results in a premature truncation of the Arid1a protein at amino acid 456 of 2285 (UniProt.org). Q456* confers a loss of function to the Arid1a protein as demonstrated by loss of Arid1a protein expression, disruption of the G2-M cell cycle checkpoint, decreased gamma-H2AX and 53BP1 foci, and decreased efficiency of homologous recombination and single-strand annealing repair of DNA in cultured cells (PMID: 26069190).",
            "references": [
                {
                    "id": 3200,
                    "pubMedId": 26069190,
                    "title": "ARID1A Deficiency Impairs the DNA Damage Checkpoint and Sensitizes Cells to PARP Inhibitors.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26069190"
                },
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 8289,
        "geneSymbol": "ARID1A",
        "terms": [
            "ARID1A",
            "B120",
            "BAF250",
            "BAF250a",
            "BM029",
            "C1orf4",
            "CSS2",
            "ELD",
            "hELD",
            "hOSA1",
            "MRD14",
            "OSA1",
            "P270",
            "SMARCF1"
        ]
    },
    "variant": "Q456*",
    "createDate": "01/28/2016",
    "updateDate": "11/30/2018",
    "referenceTranscriptCoordinates": {
        "id": 140923,
        "transcript": "NM_006015",
        "gDna": "chr1:g.26731167C>T",
        "cDna": "c.1366C>T",
        "protein": "p.Q456*",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 4432,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Rubraca (rucaparib) treatment resulted in increased apoptosis of colorectal cancer cells harboring ARID1A Q456* in culture (PMID: 26069190).",
            "molecularProfile": {
                "id": 17603,
                "profileName": "ARID1A Q456*"
            },
            "therapy": {
                "id": 906,
                "therapyName": "Rucaparib",
                "synonyms": null
            },
            "indication": {
                "id": 9256,
                "name": "colorectal cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 3200,
                    "pubMedId": 26069190,
                    "title": "ARID1A Deficiency Impairs the DNA Damage Checkpoint and Sensitizes Cells to PARP Inhibitors.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26069190"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 11888,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, colorectal cancer cells homozygous for ARID1A Q456* were sensitive to VE-821 in in vitro assays, demonstrating decrease cell survival (PMID: 27958275).",
            "molecularProfile": {
                "id": 17603,
                "profileName": "ARID1A Q456*"
            },
            "therapy": {
                "id": 2877,
                "therapyName": "VE-821",
                "synonyms": null
            },
            "indication": {
                "id": 9256,
                "name": "colorectal cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 9887,
                    "pubMedId": 27958275,
                    "title": "ATR inhibitors as a synthetic lethal therapy for tumours deficient in ARID1A.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27958275"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 8054,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, a colorectal cancer cell line homozygously expressing ARID1A Q456* demonstrated sensitivity to treatment with Sprycel (dasatinib) in culture (PMID: 27364904).",
            "molecularProfile": {
                "id": 17603,
                "profileName": "ARID1A Q456*"
            },
            "therapy": {
                "id": 717,
                "therapyName": "Dasatinib",
                "synonyms": null
            },
            "indication": {
                "id": 9256,
                "name": "colorectal cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 6543,
                    "pubMedId": 27364904,
                    "title": "Synthetic Lethal Targeting of ARID1A-Mutant Ovarian Clear Cell Tumors with Dasatinib.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27364904"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 4270,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Lynparza (olaparib) inhibited proliferation and colony formation of a colorectal cancer cell line harboring ARID1A Q456* in culture (PMID: 26069190).",
            "molecularProfile": {
                "id": 17603,
                "profileName": "ARID1A Q456*"
            },
            "therapy": {
                "id": 837,
                "therapyName": "Olaparib",
                "synonyms": null
            },
            "indication": {
                "id": 9256,
                "name": "colorectal cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 3200,
                    "pubMedId": 26069190,
                    "title": "ARID1A Deficiency Impairs the DNA Damage Checkpoint and Sensitizes Cells to PARP Inhibitors.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26069190"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 4290,
            "approvalStatus": "Preclinical - Cell line xenograft",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Talazoparib (BMN-673) inhibited colony formation and proliferation of a human colorectal cancer cell line harboring ARID1A Q456* in culture and inhibited tumor formation in colorectal cancer xenografts harboring ARID1A Q456* (PMID: 26069190).",
            "molecularProfile": {
                "id": 17603,
                "profileName": "ARID1A Q456*"
            },
            "therapy": {
                "id": 682,
                "therapyName": "Talazoparib",
                "synonyms": null
            },
            "indication": {
                "id": 9256,
                "name": "colorectal cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 3200,
                    "pubMedId": 26069190,
                    "title": "ARID1A Deficiency Impairs the DNA Damage Checkpoint and Sensitizes Cells to PARP Inhibitors.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26069190"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 11892,
            "approvalStatus": "Preclinical - Cell line xenograft",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, VX-970 treatment in colorectal cancer cells homozygous for ARID1A Q456* resulted in decreased cell survival in culture, and tumor growth inhibition in cell line xenograft models (PMID: 27958275).",
            "molecularProfile": {
                "id": 17603,
                "profileName": "ARID1A Q456*"
            },
            "therapy": {
                "id": 2879,
                "therapyName": "VX-970",
                "synonyms": null
            },
            "indication": {
                "id": 9256,
                "name": "colorectal cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 9887,
                    "pubMedId": 27958275,
                    "title": "ATR inhibitors as a synthetic lethal therapy for tumours deficient in ARID1A.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27958275"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 17603,
            "profileName": "ARID1A Q456*",
            "profileTreatmentApproaches": [
                {
                    "id": 19480,
                    "name": "EZH2 inhibitor",
                    "profileName": "ARID1A Q456*"
                }
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 140924,
            "transcript": "NM_139135",
            "gDna": "chr1:g.26731167C>T",
            "cDna": "c.1366C>T",
            "protein": "p.Q456*",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 140923,
            "transcript": "NM_006015",
            "gDna": "chr1:g.26731167C>T",
            "cDna": "c.1366C>T",
            "protein": "p.Q456*",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}